{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:50Z","timestamp":1761102290513},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bjid.2017.11.004","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T08:20:28Z","timestamp":1516263628000},"page":"1-10","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil \u2013 comparison of outcomes from different static model types"],"prefix":"10.1016","volume":"22","author":[{"given":"Laure-Anne","family":"Van Bellinghen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alen","family":"Marijam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Tannus Branco de Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse","family":"Van Vlaenderen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2017.11.004_bib0195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/irv.12036","article-title":"Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"7","author":"Savy","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.bjid.2017.11.004_bib0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bjid.2015.09.009","article-title":"Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition","volume":"20","author":"Barros","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13580","article-title":"Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation","volume":"13","author":"Burch","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bjid.2017.11.004_bib0210","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta13110","article-title":"Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no 67): a systematic review and economic evaluation","volume":"13","author":"Tappenden","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bjid.2017.11.004_bib0215","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7350","article-title":"Systematic review and economic decision modelling for the prevention and treatment of influenza A and B","volume":"7","author":"Turner","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bjid.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"e98437","DOI":"10.1371\/journal.pone.0098437","article-title":"The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model","volume":"9","author":"Van Bellinghen","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bjid.2017.11.004_bib0225","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica. Proje\u00e7\u00e3o da popula\u00e7\u00e3o por sexo e idades simples, em 1\u00b0 de julho \u2013 2000\/2060. ftp:\/\/ftp.ibge.gov.br\/Projecao_da_Populacao\/Projecao_da_Populacao_2013\/projecoes_2013_populacao_xls.zip [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0230","unstructured":"SOESPE \u2013 Sociedade Espiritossantense de Pediatria. Informe Tecnico; Campanha Nactional de Vacina\u00e7ao Contra a Influenza; Brasillia, 2014. http:\/\/soespe.com.br\/noticias\/Informe_Influenza.pdf [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0235","unstructured":"SI-PNI \u2013 Sistema de Informa\u00e7\u00e3o do Programa Nacional de Imuniza\u00e7\u00f5e. Campanha Nacional De Vacina\u00e7\u00e3o Contra Gripe 2014 \u2013 Doses Aplicadas Por Grupo Priorit\u00e1rio E Faixa Et\u00e1ria. http:\/\/pni.datasus.gov.br\/consulta_Influenza_14_selecao.asp?naofechar=N&enviar=ok&grupo=todos&faixa=todos&sel_parcial=10&sel_parcial_csv=10&sel=doses05 [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0240","series-title":"Summary Health Statistics for U.S. Children: National Health Interview Survey","author":"Centers for Disease Control","year":"2012"},{"key":"10.1016\/j.bjid.2017.11.004_bib0245","unstructured":"Centers for Disease Control. Number of respondent-reported chronic conditions from 10 selected conditions among adults aged 18 and over, by selected characteristics: United States, selected years 2002\u20132013. http:\/\/www.cdc.gov\/nchs\/data\/hus\/2014\/043.pdf [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0250","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica. T\u00e1buas de mortalidade (2000\u20132060). ftp:\/\/ftp.ibge.gov.br\/Projecao_da_Populacao\/Projecao_da_Populacao_2013\/tabuas_de_mortalidade_xls.zip [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0255","unstructured":"UK Department of Health. The seasonal flu immunisation programme 2011\/12. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/216357\/dh_128175.pdf [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0260","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2017.11.004_bib0265","unstructured":"SI-PNI \u2013 Sistema de Informa\u00e7\u00e3o do Programa Nacional de Imuniza\u00e7\u00f5e. Campanha Nacional De Vacina\u00e7\u00e3o Contra Gripe 2014 \u2013 Coberturas Vacinais. http:\/\/pni.datasus.gov.br\/consulta_Influenza_14_selecao.asp?naofechar=N&enviar=ok&grupo=todos&faixa=todos&sel=coberturas&sel_parcial=10&sel_parcial_csv=10 [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0270","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2017.11.004_bib0275","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2017.11.004_bib0280","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","author":"Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2017.11.004_bib0285","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-11-153","article-title":"Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis","volume":"11","author":"Tricco","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.bjid.2017.11.004_bib0290","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.004_bib0295","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/jmv.23684","article-title":"Evolutionary pattern of reemerging influenza B\/Victoria lineage viruses in Sao Paulo Brazil, 1996\u20132012: implications for vaccine composition strategy","volume":"85","author":"Paiva","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.bjid.2017.11.004_bib0300","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1590\/0074-02760150044","article-title":"Detection of influenza B lineages from 2001 to 2013 in a tertiary hospital in the city of Sao Paulo Brazil","volume":"110","author":"Perosa","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bjid.2017.11.004_bib0305","unstructured":"World Health Organisation. FluNet Database for influenza virological surveillance. https:\/\/extranet.who.int\/sree\/Reports?op=vs&path=\/WHO_HQ_Reports\/G5\/PROD\/EXT\/FluNetLaboratorySurveillanceData [accessed 08.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0310","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2334-13-343","article-title":"Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged \u226418 years","volume":"13","author":"Kieninger","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2017.11.004_bib0315","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jpids\/piv041","article-title":"Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in US children 6\u201335 months of age during 2013\u20132014: results from a phase II randomized trial","volume":"5","author":"Wang","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.bjid.2017.11.004_bib0320","unstructured":"SI-PNI \u2013 Sistema de Informa\u00e7\u00e3o do Programa Nacional de Imuniza\u00e7\u00f5e. Campanha Nacional De Vacina\u00e7\u00e3o Contra Gripe 2014 \u2013 Doses Aplicadas Em Crian\u00e7as De 6 Meses A <2 Anos De Idade Por Tipo De Dose E Taxa De Abandono. http:\/\/pni.datasus.gov.br\/consulta_Influenza_14_selecao.asp?naofechar=N&enviar=ok&grupo=todos&faixa=todos&sel_parcial=10&sel_parcial_csv=10&sel=doses06 [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0325","unstructured":"Portal da Sa\u00fade. Tratamento influenza \u2013 Posologia e Administra\u00e7\u00e3o. http:\/\/portalsaude.saude.gov.br\/index.php\/tratamento-influenza [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0330","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/14656566.9.2.151","article-title":"Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children","volume":"9","author":"Gums","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bjid.2017.11.004_bib0335","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1185\/030079907X242520","article-title":"Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study","volume":"23","author":"Blumentals","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bjid.2017.11.004_bib0340","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6963-1-8","article-title":"Impact of patient characteristics on the risk of influenza\/ILI-related complications","volume":"1","author":"Irwin","year":"2001","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.bjid.2017.11.004_bib0345","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40258-013-0020-6","article-title":"Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database","volume":"11","author":"Karve","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.bjid.2017.11.004_bib0350","unstructured":"ANVISA. Agencia Nacional de Vigilancia Sanitaria. http:\/\/portal.anvisa.gov.br [accessed 05.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0355","unstructured":"DATASUS. Departamento de Inform\u00e1tica do SUS. http:\/\/sigtap.datasus.gov.br\/tabela-unificada\/app\/sec\/inicio.jsp [accessed 12.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0360","unstructured":"Diario Oficial da Uniao. ISSN 1677-7069N\u030a 147, 2014, p 376. http:\/\/pesquisa.in.gov.br\/imprensa\/jsp\/visualiza\/index.jsp?data=04\/08\/2014&jornal=3&pagina=376&totalArquivos=496 [accessed 13.08.15]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0365","unstructured":"DATASUS. TabNet \u2013 Morbidade Hospitalar Do SUS \u2013 Por Local de interna\u00e7ao \u2013 Brasil. http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sih\/cnv\/niuf.def [accessed 12.07.16]."},{"key":"10.1016\/j.bjid.2017.11.004_bib0370","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00005650-199806000-00002","article-title":"Toward consistency in cost-utility analyses: using national measures to create condition-specific values","volume":"36","author":"Gold","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.bjid.2017.11.004_bib0375","series-title":"Ranking vaccines: a prioritization framework: Phase I: Demonstration of concept and a software blueprint","author":"IOM (Institute of Medicine)","year":"2012"},{"key":"10.1016\/j.bjid.2017.11.004_bib0380","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0002-9343(02)01222-6","article-title":"Cost-effectiveness of newer treatment strategies for influenza","volume":"113","author":"Smith","year":"2002","journal-title":"Am J Med"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867017306542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T17:26:45Z","timestamp":1535131605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867017306542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1413867017306542"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2017.11.004","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil \u2013 comparison of outcomes from different static model types","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}